Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

Bruce D Wines; Liriye Kurtovic; Halina M Trist; Sandra Esparon; Ester Lopez; Klasina Chappin; Li-Jin Chan; Francesca L Mordant; Wen Shi Lee; Nicholas A Gherardin; Sheila K Patel; Gemma E Hartley; Phillip Pymm; James P Cooney; James G Beeson; Dale I Godfrey; Louise M Burrell; Menno C van Zelm; Adam K Wheatley; Amy W Chung; Wai-Hong Tham; Kanta Subbarao; Stephen J Kent; P Mark Hogarth

doi:10.3389/fimmu.2022.1122516

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

Front Immunol. 2023 Jan 10:13:1122516. doi: 10.3389/fimmu.2022.1122516. eCollection 2022.

Authors

Bruce D Wines^{1

2

3

4}, Liriye Kurtovic^{2

3}, Halina M Trist¹, Sandra Esparon¹, Ester Lopez⁵, Klasina Chappin¹, Li-Jin Chan^{6

7}, Francesca L Mordant⁵, Wen Shi Lee⁵, Nicholas A Gherardin⁵, Sheila K Patel⁸, Gemma E Hartley³, Phillip Pymm^{6

7}, James P Cooney^{6

7}, James G Beeson^{2

3

9

10}, Dale I Godfrey⁵, Louise M Burrell⁸, Menno C van Zelm^{3

11}, Adam K Wheatley^{5

12}, Amy W Chung⁵, Wai-Hong Tham^{6

7}, Kanta Subbarao^{5

13}, Stephen J Kent^{5

12

14}, P Mark Hogarth^{1

2

3}

Affiliations

¹ Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.
² Life Sciences, Burnet Institute, Melbourne, VIC, Australia.
³ Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.
⁴ Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia.
⁵ Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
⁶ Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
⁷ Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.
⁸ Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.
⁹ Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
¹⁰ Department of Microbiology, Monash University, Clayton VIC, Australia.
¹¹ Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Alfred Hospital, Melbourne, VIC, Australia.
¹² Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.
¹³ World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
¹⁴ Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.

Abstract

[This corrects the article .].

Keywords: ACE2-Fc; ADCC; COVID-19; SARS-CoV-2; antibody effector function; complement; coronavirus; neutralization.

Copyright © 2023 Wines, Kurtovic, Trist, Esparon, Lopez, Chappin, Chan, Mordant, Lee, Gherardin, Patel, Hartley, Pymm, Cooney, Beeson, Godfrey, Burrell, van Zelm, Wheatley, Chung, Tham, Subbarao, Kent and Hogarth.

Publication types

Published Erratum